| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/19/2008 | US20080147045 Use of VEGF-C or VEGF-D in Reconstructive Surgery |
| 06/19/2008 | US20080146808 Antiapoptosis; cancers; inhibiting the caspases; |
| 06/19/2008 | US20080146786 Fluorescence resonance energy transfer (Fret) on substrates comprising syntaxin or mimetics thereof; for clostridium and tetanus toxins |
| 06/19/2008 | US20080146783 Loading solution onto a hydrophobic interaction chromatography matrix equilibrated in aqueous buffer at a salt concentration high enough to promote matrix-protein interactions, applying a gradient of decreasing salt concentration, and collecting the conjugate, leaving the unconjugated albumin |
| 06/19/2008 | US20080146782 produced by the enzyme mediated formation of a conjugate between a glycosylated or non-glycosylated peptide and an enzymatically transferable saccharyl moiety that includes a modifying group, such as a polymeric modifying group such as poly(ethylene glycol), within its structure |
| 06/19/2008 | US20080146781 Modified Human Four Helical Bundle Polypeptides and Their Uses |
| 06/19/2008 | US20080146779 Novel Melanocortin Receptor Templates, Peptides, and Use Thereof |
| 06/19/2008 | US20080146596 Such as (R)-2-(4-((3'-chlorobiphenyl-4-yl)(hydroxy)methyl)piperidin-1-yl)pyrimidin-5-ol for treating age-associated memory impairment, Alzheimer's disease, attention-deficit/hyperactivity disorder, autism, Down syndrome, Fragile X syndrome, Huntington's disease, Parkinson's disease, or schizophrenia |
| 06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
| 06/19/2008 | US20080146510 For suppressing cell proliferation/tumor growth or modulating immune system by transformation of T-lymphocytes or enhancement of natural killer cells |
| 06/19/2008 | US20080146509 delivery agent, parathyroid hormone, and calcitonin. This composition exhibits increased delivery of parathyroid hormone and/or calcitonin and is useful for the treatment of osteoporosis. The composition also permits simultaneous oral delivery of parathyroid hormone and calcitonin |
| 06/19/2008 | US20080146508 Soluble cyclic analogues of beta amyloid peptide |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 06/19/2008 | US20080146502 method for modulating the sensation of satiety perception and to agents useful for same. Such agents are useful in modulating, controlling or otherwise affecting inter alia obesity, anorexia, weight maintenance, metabolic energy levels and/or inflammatory conditions in a subject |
| 06/19/2008 | US20080146501 identifying a subject at risk for developing AMD are disclosed. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. Therapeutic compositions and methods are also provided for delaying the progression or onset of the development |
| 06/19/2008 | US20080146500 encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes. |
| 06/19/2008 | US20080146499 Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 |
| 06/19/2008 | US20080146496 Novel Melanocortin Receptor Templates, Peptides, and Use Thereof |
| 06/19/2008 | US20080146494 Glycoconjugation methods and proteins/peptides produced by the methods |
| 06/19/2008 | US20080146493 increasing Na ion transport and/or epithelial fluid transport in a vertebrate by administering an effective amount of haptoglobin or haptoglobin and hemoglobin. The invention also provides a new therapeutic approach for treating disorders associated with insufficient epithelial Na ion fluid transport |
| 06/19/2008 | US20080146492 Insulin production methods and pro-insulin constructs |
| 06/19/2008 | US20080146460 Optical probes and assays |
| 06/19/2008 | US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/19/2008 | US20080145928 Nucleotide sequences coding transcription factor for use in prevention and treatment of cell proliferative disorders |
| 06/19/2008 | US20080145927 Stresscopins and their uses |
| 06/19/2008 | US20080145916 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 06/19/2008 | US20080145913 Endonuclease which reasserts mutations between related polynucleotides via formation of heteroduplex molecules and then addressing mismatches |
| 06/19/2008 | US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 06/19/2008 | US20080145897 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, Isolated PEF protein, and methods for purifying and identifying |
| 06/19/2008 | US20080145896 Anti Hiv-I Bacterial and Baculovirus Recombinant Epap-1 |
| 06/19/2008 | US20080145893 Using chineese hamster ovaries as bioreactors for biosynthesis of immunoglobulin lihgt and heavy chains |
| 06/19/2008 | US20080145892 Expression vector comprising DBV gene cluster for use in transformation and synthesis of preferential peptide antibiotic |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145867 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145859 Diagnosis and treatment of cancer |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145839 Method and Nucleic Acids For the Differentiation of Astrocytoma, Oligoastrocytoma and Oligodenroglioma Tumor Cells |
| 06/19/2008 | US20080145384 stimulating an immune response against a secreted enterohemorragic Escherichia coli (EHEC) antigen; cell culture supernatant is cultured under conditions that favor Type III antigen secretion; prevent infections |
| 06/19/2008 | US20080145383 Method for Solubilizing Peptide Mixtures |
| 06/19/2008 | US20080145379 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/19/2008 | US20080145378 Means and Methods for Breaking Noncovalent Binding Interactions Between Molecules |
| 06/19/2008 | US20080145377 G-CSF Polypeptides And Uses Thereof |
| 06/19/2008 | US20080145369 Using pc-cell-derived growth factor concentration as diagnostic indicator of cell proliferative disorders |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145365 Human and mammalian stem cell-derived neuron survival factors |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145356 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/19/2008 | US20080145339 Modified rolling circle initiator protein for use as therapeutic tool in suppression of viral replication and disorders |
| 06/19/2008 | US20080145324 Lipophilic ultraviolet screening agent; tanning protectant in cosmetic and dermatologic products; topical; photoprotective effectiveness and solubility by adding at least one silicon-containing s-triazine compound substituted with two aminobenzoate or aminobenzamide groups |
| 06/19/2008 | US20080145315 Bioassay for monitoring protein-protein interactions associated with absorption, distribution, metabolism and excretion in animals and/or cells |
| 06/19/2008 | US20080143574 A-D converter, A-D convert method, and A-D convert program |
| 06/19/2008 | DE102006059574A1 Fusion protein useful for detecting autoantibodies to bullous pemphigoid protein BP180 comprises several copies of the amino acid sequence of the NC16A1-5 domain of BP180 |
| 06/19/2008 | CA2763879A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 06/19/2008 | CA2707542A1 Casein-derived peptides having anxiolytic activity |
| 06/19/2008 | CA2673085A1 Transferrin fusion protein libraries |
| 06/19/2008 | CA2672628A1 A homogeneous time resolved fluorescence based test system for paramyxoviridae |
| 06/19/2008 | CA2672406A1 Novel compounds and their effects on feeding behaviour |
| 06/19/2008 | CA2672297A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 06/19/2008 | CA2672215A1 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | CA2672055A1 Treatment of cachexia |
| 06/19/2008 | CA2672036A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 06/19/2008 | CA2671863A1 Method of treating acute renal failure with thrombomodulin variants |
| 06/19/2008 | CA2671732A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/19/2008 | CA2671341A1 Plants having enhanced seed yield-related traits and a method for making the same |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/18/2008 | EP1933150A1 Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof |
| 06/18/2008 | EP1932920A1 Method for screening of substance effective on disease using gpr120 and phospholipase |
| 06/18/2008 | EP1932915A2 Materials and methods relating to improved vaccination strategies |
| 06/18/2008 | EP1932912A1 Recombinant vector capable of increasing secretion of koji mold protease |
| 06/18/2008 | EP1932907A1 Crystal structure of the catalytic domain of tolloid-like protease 1 and uses thereof |
| 06/18/2008 | EP1932855A1 Lactoferrin complex and method of producing the same |
| 06/18/2008 | EP1932854A1 Lysosomal associated membrane protein (LAMP) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 06/18/2008 | EP1932852A1 Novel taxane related peptides and uses thereof |
| 06/18/2008 | EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host |
| 06/18/2008 | EP1932539A2 Signal-1/Signal-2 bifunctional peptide inhibitors |
| 06/18/2008 | EP1932535A2 Stimulation of beta cell profileration |
| 06/18/2008 | EP1931788A2 Plants having increased yield and method for making the same |
| 06/18/2008 | EP1931783A1 Chimeric hcn channels |
| 06/18/2008 | EP1931781A2 Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| 06/18/2008 | EP1931778A2 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-Bl00 EXPRESSION |
| 06/18/2008 | EP1931708A1 Il-17c antagonists and methods of using the same |
| 06/18/2008 | EP1931707A1 Rat trpm7 polynucleotide and encoded protein |
| 06/18/2008 | EP1931706A1 Collagen receptor i-domain binding modulators |
| 06/18/2008 | EP1931705A2 Method for amidating polypeptides with basic aminoacid c- terminals by means of specific endoproteases |
| 06/18/2008 | EP1931704A1 Production and purification of il-29 |
| 06/18/2008 | EP1931703A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 06/18/2008 | EP1931702A1 Silk proteins |
| 06/18/2008 | EP1931701A1 Agent and compositions comprising the same for inhibiting lipases and/or phospholipases in body fluids, cells and tissues |
| 06/18/2008 | EP1931700A1 FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF |
| 06/18/2008 | EP1931699A2 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 06/18/2008 | EP1931698A1 Rapid production of high titer virus |
| 06/18/2008 | EP1931697A2 Il-17a and il-17f antagonists and methods of using the same |
| 06/18/2008 | EP1931695A1 Prion-specific peptoid reagents |
| 06/18/2008 | EP1931389A1 A vaccine |